Human serum albumin-poly(Lactide)-conjugated self-assembly NPs for targeted docetaxel delivery and improved therapeutic efficacy in oral cancer.

[1]  B. Ghosh,et al.  Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer , 2022, Journal of drug targeting.

[2]  B. Ghosh,et al.  Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer. , 2022, Carbohydrate polymers.

[3]  Fenglei Gao,et al.  Smart PdH@MnO2 Yolk-Shell Nanostructures for Spatiotemporally Synchronous Targeted Hydrogen Delivery and Oxygen-Elevated Phototherapy of Melanoma. , 2022, ACS nano.

[4]  O. Madkhali,et al.  Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer , 2022, Scientific Reports.

[5]  B. Ghosh,et al.  Oleanolic Acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma. , 2022, International journal of pharmaceutics.

[6]  Y. Wang,et al.  Multitarget Reaction Programmable Automatic Diagnosis and Treatment Logic Device. , 2021, ACS nano.

[7]  Y. Zhen,et al.  The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy. , 2021, International journal of biological macromolecules.

[8]  Xiaoying Wang,et al.  A Novel SimpleDrop Chip for 3D Spheroid Formation and Anti-Cancer Drug Assay , 2021, Micromachines.

[9]  Su Jeong Park,et al.  Stereocomplex Polylactide for Drug Delivery and Biomedical Applications: A Review , 2021, Molecules.

[10]  J. Tuszynski,et al.  The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. , 2021, Molecular pharmaceutics.

[11]  A. Bahkali,et al.  PGMD/curcumin nanoparticles for the treatment of breast cancer , 2021, Scientific Reports.

[12]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[13]  Jianqing Liang,et al.  Current Trends of Targeted Drug Delivery for Oral Cancer Therapy , 2020, Frontiers in Bioengineering and Biotechnology.

[14]  Zhipeng Gu,et al.  Nanotechnology-based drug delivery systems for enhanced diagnosis and therapy of oral cancer. , 2020, Journal of materials chemistry. B.

[15]  M. Tiwari,et al.  Critical role of three-dimensional tumorsphere size on experimental outcome. , 2020, BioTechniques.

[16]  B. Ghosh,et al.  Oleanolic acid-conjugated poly (D, l-lactide)-based micelles for effective delivery of doxorubicin and combination chemotherapy in oral cancer , 2020 .

[17]  M. Guan,et al.  Carbon Nitride Hollow Theranostic Nanoregulators Executing Laser-Activatable Water Splitting for Enhanced Ultrasound/Fluorescence Imaging and Cooperative Phototherapy. , 2020, ACS nano.

[18]  I. Estrela-Lopis,et al.  Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells , 2020, Journal of Nanobiotechnology.

[19]  Seyedehsara Masoomi Dezfooli,et al.  Nanoantioxidants: Recent Trends in Antioxidant Delivery Applications , 2019, Antioxidants.

[20]  D. Hwang,et al.  Size‐Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting , 2019, Advanced healthcare materials.

[21]  Mohammad Hasanzadeh,et al.  The potential of nanomaterials in theranostics of oral squamous cell carcinoma: Recent progress , 2019, TrAC Trends in Analytical Chemistry.

[22]  Baojun Xu,et al.  Phloretin loaded chitosan nanoparticles augments the pH-dependent mitochondrial-mediated intrinsic apoptosis in human oral cancer cells. , 2019, International journal of biological macromolecules.

[23]  Jingjing Li,et al.  Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging. , 2019, ACS nano.

[24]  J. Xie,et al.  Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation , 2019, BioMedical Engineering OnLine.

[25]  V. Addepalli,et al.  Preventive measures in oral cancer: An overview. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  W. Jacquet,et al.  The Mucosal Scarring Index: reliability of a new composite index for assessing scarring following oral surgery , 2018, Clinical Oral Investigations.

[27]  Ying Hu,et al.  Co-delivery of dihydroartemisinin and docetaxel in pH-sensitive nanoparticles for treating metastatic breast cancer via the NF-κB/MMP-2 signal pathway , 2018, RSC advances.

[28]  Jing Zhang,et al.  Nanotechnology: a promising method for oral cancer detection and diagnosis , 2018, Journal of Nanobiotechnology.

[29]  M. Eghbal,et al.  Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB. , 2017, Anti-cancer agents in medicinal chemistry.

[30]  A. Chakravarti,et al.  Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy. , 2017, Cancer research.

[31]  B. Ghosh,et al.  Polylactide-Based Block Copolymeric Micelles Loaded with Chlorin e6 for Photodynamic Therapy: In Vitro Evaluation in Monolayer and 3D Spheroid Models. , 2017, Molecular pharmaceutics.

[32]  Zhirong Zhang,et al.  Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity , 2017, Journal of drug targeting.

[33]  N. Khalil,et al.  Poly(lactic acid) nanoparticles loaded with ursolic acid: Characterization and in vitro evaluation of radical scavenging activity and cytotoxicity. , 2017, Materials science & engineering. C, Materials for biological applications.

[34]  B. Ghosh,et al.  Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy , 2017, Drug delivery.

[35]  J. Marks,et al.  Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids , 2016, Oncotarget.

[36]  S. Davaran,et al.  A simple improved desolvation method for the rapid preparation of albumin nanoparticles. , 2016, International journal of biological macromolecules.

[37]  Michael R Hamblin,et al.  Albumin nanostructures as advanced drug delivery systems , 2016, Expert opinion on drug delivery.

[38]  Dinesh Kumar,et al.  Conjugation of Docetaxel with Multiwalled Carbon Nanotubes and Codelivery with Piperine: Implications on Pharmacokinetic Profile and Anticancer Activity. , 2016, Molecular pharmaceutics.

[39]  Yaping Li,et al.  Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro , 2016, Acta Pharmacologica Sinica.

[40]  K. Howard,et al.  Albumin-based drug delivery: harnessing nature to cure disease , 2016, Molecular and Cellular Therapies.

[41]  Alessandro Bevilacqua,et al.  3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained , 2016, Scientific Reports.

[42]  M. Momin,et al.  Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy. , 2016, Critical reviews in therapeutic drug carrier systems.

[43]  B. Ghosh,et al.  Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study , 2016, Pharmaceutical Research.

[44]  Ji Hee Kang,et al.  Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  J. Andersen,et al.  The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Zhiyuan Hu,et al.  Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp , 2015, PloS one.

[47]  Shufeng Zhou,et al.  A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells , 2015, Drug design, development and therapy.

[48]  Liangzhu Feng,et al.  Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy. , 2015, ACS nano.

[49]  Chia-Che Ho,et al.  The pH-controlled nanoparticles size of polydopamine for anti-cancer drug delivery , 2013, Journal of Materials Science: Materials in Medicine.

[50]  Ahmed O Elzoghby,et al.  Albumin-based nanoparticles as potential controlled release drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Bikram Singh,et al.  Development of biodegradable nanoparticles for delivery of quercetin. , 2010, Colloids and surfaces. B, Biointerfaces.

[52]  M J Hawkins,et al.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[53]  Yan Zhang,et al.  Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[54]  M. Otagiri,et al.  Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress. , 2004, Biochimica et biophysica acta.

[55]  Boris Zhivotovsky,et al.  DNA damage-induced apoptosis , 2004, Oncogene.

[56]  M. Lisanti,et al.  The Caveolin genes: from cell biology to medicine , 2004, Annals of medicine.

[57]  J. Verweij,et al.  Pharmacological Effects of Formulation Vehicles , 2003, Clinical pharmacokinetics.